Filing Details
- Accession Number:
- 0001562180-24-005791
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-07-17 19:56:52
- Reporting Period:
- 2024-07-15
- Accepted Time:
- 2024-07-17 19:56:52
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1831363 | Terns Pharmaceuticals Inc. | TERN | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1799780 | M. Jill Quigley | C/O Terns Pharmaceuticals, Inc. 1065 East Hillsdale Blvd., Suite 100 Foster City CA 94404 | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-07-15 | 14,365 | $1.82 | 44,365 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-07-15 | 14,365 | $10.00 | 30,000 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2024-07-16 | 400 | $1.82 | 30,400 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-07-16 | 400 | $10.00 | 30,000 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2024-07-15 | 14,365 | $0.00 | 14,365 | $1.82 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2024-07-16 | 400 | $0.00 | 400 | $1.82 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 17,635 | 2023-06-12 | 2032-06-15 | No | 4 | M | Direct |
| 17,235 | 2023-06-12 | 2032-06-15 | No | 4 | M | Direct |
Footnotes
- The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 18, 2024.
- This sale price represents the weighted average sale price of the shares sold ranging from $10.00 to $10.01 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- The option vested in full immediately prior to the Annual Meeting following the date of grant.
Billionaire Hedge Funds
